The findings demonstrated that both FDX1 and DALT were independent prognostic markers for poor survival in ccRCC patients, showing a strong positive correlation as well as the fact that they were correlated significantly with immune infiltration and immune checkpoints. The gene discussed is FDX1; the disease is nonpapillary renal cell carcinoma.